Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Acupuncture needles take on cancer stress: new trial tests weekly sessions

NCT ID NCT07132034

First seen Jan 18, 2026 · Last updated Jun 21, 2026 · Updated 29 times

Summary

This study tests whether eight weekly acupuncture sessions can lower stress in breast cancer patients who finished primary treatment in the last six months. About 112 participants will be randomly assigned to acupuncture or standard supportive care. The main goal is to measure stress levels after eight weeks using a standard questionnaire.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital Basel

    Basel, 4031, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

acupuncture

What this could lead to

If it works, this could offer a drug-free way to ease stress for breast cancer survivors after primary treatment.

What could go wrong

This is a small, early-stage study with no blinding, so results may be influenced by placebo effects. Acupuncture is generally safe but may cause minor bruising or soreness.

Conditions

The condition(s) this trial relates to.

breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.